During the past decade, Uherskohradistska nemocnice a.s. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Uherskohradistska nemocnice a.s." are "Rheumatoid Arthritis" (2 trials), "Ankylosing Spondylitis" (1 trials), "Castration-Resistant Prostatic Cancer" (1 trials), "Mixed Leg Ulcers" (1 trials) and "Uterine Fibroids" (1 trials). Many other conditions were trialed in "Uherskohradistska nemocnice a.s." in a lesser frequency.

Most popular intervention types in "Uherskohradistska nemocnice a.s." are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tofacitinib" (2 trials), "Abiraterone Acetate" (1 trials), "Mepilex Ag" (1 trials), "Mepilex without Ag" (1 trials) and "New Formulation of Niraparib and Abiraterone Acetate (AA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uherskohradistska nemocnice a.s." are 4 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Uherskohradistska nemocnice a.s.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Uherskohradistska nemocnice a.s., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Uherskohradistska nemocnice a.s., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".